SCHEMBL10122754

SCHEMBL10122754

Brc1ccc2c(c1)oc1cc3ccccc3cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.48
GRM4 Q14833 2/20 0.45
MAOB P27338 2/20 0.41
AHR P35869 3/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
MAOA P21397 1/20 0.39
CBX7 O95931 2/20 0.38
CDYL Q9Y232 2/20 0.38
CDY1; CDY1B Q9Y6F8 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
ALOX15 P16050 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30277934 1.00 CYP2A6 (0.48) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL29596943 1.00 CYP2A6 (0.48) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL29571824 0.89 CYP2A6 (0.48) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL22688479 0.89 CYP2A6 (0.59) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL16067567 0.89 CYP2A6 (0.48) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL17382962 0.86 MAOB (0.47) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL31451500 0.86 MAOB (0.47) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL22337013 0.86 MAOA (0.46) CYP2A6GRM4MEN1KMT2AKDM4E
SCHEMBL22254459 0.85 CYP2A6 (0.45) CYP2A6GRM4MAOBAHRMEN1
SCHEMBL22133389 0.84 AHR (0.49) CYP2A6MAOBAHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119409691-A Organic electroluminescent compound and application thereof 宁波卢米蓝新材料有限公司 2025-02-11 CN disclosed
US-11713291-B2 Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-08-01 US disclosed
US-11713291-B2 Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-08-01 US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 US disclosed
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-13 US disclosed
WO-2023085606-A1 ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2023-05-19 WO disclosed
CN-114788030-A Organic electroluminescent element comprising organic compound, electronic device comprising the same 德山新勒克斯有限公司 2022-07-22 CN disclosed
CN-114641870-A Organic electric element comprising a plurality of luminescence auxiliary layers and electronic device comprising same 德山新勒克斯有限公司 2022-06-17 CN disclosed
CN-114207861-A Organic electronic device 德山新勒克斯有限公司 2022-03-18 CN disclosed
CN-114207859-A Organic electronic device 德山新勒克斯有限公司 2022-03-18 CN disclosed
US-8866135-B2 Anthracene derivative and organic electroluminescent element using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-10-21 US disclosed
US-8866135-B2 Anthracene derivative and organic electroluminescent element using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-10-21 US disclosed
WO-2014141725-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME 出光興産株式会社 (JP) 2014-09-18 WO disclosed
US-20140159005-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IIDEMITSU KOSAN CO., LTD (JP) 2014-06-12 US disclosed
US-20140159005-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IIDEMITSU KOSAN CO., LTD (JP) 2014-06-12 US disclosed
US-8629430-B2 Anthracene derivative and organic electroluminescent element using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-01-14 US disclosed
US-8629430-B2 Anthracene derivative and organic electroluminescent element using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-01-14 US disclosed
US-20120138914-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138914-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
WO-2010137285-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME 出光興産株式会社 (JP) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140159005-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME SOX18, ANXA1, ANXA11 CYP2A6 1630/4885GRM4 4756/4885MAOB 1666/4885
US-11678577-B2 Organic electronic element comprising compound for organic electronic element and an electronic device thereof ESR1, EML4, OCIAD2 CYP2A6 911/4885GRM4 1305/4885MAOB 1023/4885
US-11713291-B2 Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof PIEZO1, ORAI2, EXOC1 CYP2A6 3062/4885GRM4 1824/4885MAOB 2572/4885
US-20120138914-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME SOX18, ANXA1, ANXA11 CYP2A6 1630/4885GRM4 4756/4885MAOB 1666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.